Global Drug Discovery Services Market Research Reveals Size, Share, Key Growth Factors, Revenue Details and Forecast till 2026
The rapidly expanding drug discovery services market is the focus of a new report added to the market intelligence repository of Fact.MR. This 170-page broad study is headlined as “Drug Discovery Services Market Research Forecast, Trend Analysis & Competition Tracking: Global Review 2017 to 2026” which noticeably examines the prospects of the global drug discovery services industry till the end of 2022, using the market’s development trajectory in the recent past as the key indicator of actionable insights into the market’s growth pattern. A blend of primary & secondary research has been implemented for offering estimates and forecasts on the concerned market.Request Sample Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=375
According to a study by Fact.MR, the global market for drug discovery services is likely to experience strong growth. By 2026 end, the global market for drug discovery services is also estimated to bring in US$ 16,800.1 million revenue. Advancements in the drug discovery technologies are leading to the better drug discovery services. Some of the upcoming trends in the market in terms of drug discovery technology are regulatory initiatives towards pharmacogenomics technology, combinatorial chemistry technology, etc. there has also been an increase in the adoption of label-free techniques.
Hit-To-Lead Identification to Gain Maximum Traction
Compared to the various processes in the drug discovery services, Hit-To-Lead identification is anticipated to gain maximum traction. Hit-To-Lead identification is likely to exceed US$ 6,900 million revenue towards 2026 end. Increasing research based on the High-Throughput Screening (HTS) is the main factor driving the use of hit-to-lead identification process.
Medicinal Chemistry to be the Largest Type of Drug Discovery Services
Medicinal chemistry is projected to emerge as the largest type in the drug discovery services market. Medicinal chemistry is estimated to bring in close to US$ 6,100 million revenue. There has been an increase in the outsourcing by pharmaceutical companies, this is emerging as the driving factor. Many drug discovery services providers based in Asia are increasing their foothold in North America and Europe.
Small Molecules to Witness Highest Growth in Terms of Revenue
Compared to biologics, small molecules are estimated to account for the highest share in terms of revenue. By 2026 end, small molecules are estimated to exceed US$ 10,800 million revenue. Small molecules are gaining traction as they are easy to characterize, simple and well defined. Also, small molecules can easily enter cells, and can cause cancer cells to die.
Oncology to Hold Largest Revenue Share in the Therapeutic Area
By therapeutic area, oncology is likely to emerge as the largest segment throughout the forecast period. Towards 2026 end, oncology is estimated to exceed US$ 6,900 million revenue. Increasing number of people suffering from cancer is resulting in the high demand for cancer therapies. Hence, oncology is anticipated to experience a significant growth in the coming years.
View Report@ https://www.factmr.com/report/375/drug-discovery-services-market
Table of Contents:
Global Economic Outlook
Global Drug Discovery Services Market – Executive Summary
Global Drug Discovery Services Market Overview
3.1. Introduction
3.1.1. Global Drug Discovery Services Market Taxonomy
3.1.2. Global Drug Discovery Services Market Definition
3.2. Global Drug Discovery Services Market Size (US$ Mn) and Forecast, 2012-2026
3.2.1. Global Drug Discovery Services Market Y-o-Y Growth
3.3. Global Drug Discovery Services Market Dynamics
3.4. Supply Chain
3.5. Cost Structure
3.6. PESTL Analysis
3.7. Product Life Cycle Analysis
3.8. Drug Discovery & Development Process
3.9. Roadmap to Optimize Regulatory and Commercial Success
3.10. Evolution of R&D Drug Discovery Outsourcing
3.11. Service Provider List
3.12. Key Participants Market Presence (Intensity Map) By Region
Global Drug Discovery Services Market Analysis and Forecast 2012-2026
4.1. Global Drug Discovery Services Market Size and Forecast By Process , 2012-2026
4.1.1. Target Selection Market Size and Forecast, 2012-2026
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region
Continued……..
Check Discount on this Report@ https://www.factmr.com/connectus/sample?flag=D&rep_id=375
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Follow Us on Linkedin: https://www.linkedin.com/company/factmr/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Drug Discovery Services Market Research Reveals Size, Share, Key Growth Factors, Revenue Details and Forecast till 2026 here
News-ID: 1081338 • Views: …
More Releases from Fact.MR
Demand for Dry Powder Inhalers is forecasted to reach a market value of US$ 2.2 …
The global dry powder inhaler (DPI) market is estimated to be worth US$ 1.1 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.2% to reach a valuation of US$ 2.2 billion by the end of 2034, according to a comprehensive study conducted by Fact.MR.
Download Sample Copy of This Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=7083
The demand for dry powder inhalers is expected to rise due to the…
Global ISO Certification Market is projected to expand at a CAGR of 15.2% from 2 …
According to a recently released Fact.MR analysis, the global market for ISO certification is expected to be valued at US$ 16.14 billion by 2024. By the end of 2034, revenue from ISO certification is expected to grow at a 15.2% compound annual growth rate and reach a market valuation of US$ 66.25 billion.
In order to prove compliance with environmental, quality, or information security rules, a variety of sectors require ISO…
Gluten-free Bakery Products Market is expected to grow at a CAGR of 9.8% from 20 …
The gluten-free bakery products market is a dynamic sector influenced by various factors such as consumer dietary preferences, health trends, and advancements in food technology. As awareness of celiac disease and gluten sensitivities grows, so does the demand for gluten-free alternatives in baked goods.
Download Sample Copy of This Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=3035
Gluten is a protein fraction generated from wheat, rye, barley, oats, and their derivatives and hybrids. It is an essential part…
Pet Grooming Services Market is projected to expand at a CAGR of 7.2% from 2024 …
The global pet grooming services market is anticipated to rise at a compound annual growth rate (CAGR) of 7.2%, from a value of US$ 3.3 billion in 2024 to US$ 6.7 billion by the end of 2034, according to the most recent market research analysis published by Fact.MR.
Pets are now considered members of the family by many. Pet owners want the best for their furry pals, just as much as…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…